Pulmonary hypertension and systemic vasoconstriction may offset the benefits of acellular hemoglobin blood substitutes. [electronic resource]
Producer: 19970710Description: 847-54; discussion 854-6 p. digitalISSN:- 0022-5282
- Albumins -- therapeutic use
- Animals
- Aspirin -- adverse effects
- Cerebrovascular Circulation -- drug effects
- Constriction, Pathologic -- chemically induced
- Disease Models, Animal
- Drug Evaluation, Preclinical
- Female
- Hemoglobins -- adverse effects
- Hypertension, Pulmonary -- chemically induced
- Pulmonary Wedge Pressure -- drug effects
- Shock, Hemorrhagic -- therapy
- Splanchnic Circulation -- drug effects
- Swine
- Vascular Resistance -- drug effects
No physical items for this record
Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.